Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1051 of 5804
-
Nerve-Cutting surgery may boost diabetes remission after gastric bypass
Disease control Recruiting nowThis randomized, triple-blind clinical trial investigates whether adding truncal vagotomy to Roux-en-Y gastric bypass (RYGB) enhances remission of type 2 diabetes mellitus (T2DM) in patients with obesity. The study explores whether modulation of vagal signaling provides superior …
Phase: NA • Sponsor: University Research Institute for the Study of Genetic & Malignant Disorders in Childhood • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New enzyme pill could help cystic fibrosis patients digest food better
Disease control Recruiting nowIn this study, ANG003, a pancreatic enzyme replacement therapy (PERT; commonly called "enzymes"), is being investigated as a potential treatment for exocrine pancreatic insufficiency (EPI). People with EPI due to Cystic Fibrosis (CF) may be eligible to participate in this study. …
Phase: PHASE2 • Sponsor: Anagram Therapeutics, Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New pill could help when steroids fail for bulging eyes
Disease control Recruiting nowThyroid Eye Disease (TED), also known as Graves' orbitopathy, is an autoimmune condition that causes inflammation and tissue expansion behind the eyes, leading to bulging eyes (proptosis), double vision, and pain. Currently, intravenous glucocorticoids (steroids) are the standard…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Heart attack prevention showdown: plaque scans vs. blood flow tests
Disease control Recruiting now1. Study Purpose This study aims to compare clinical outcomes between two revascularization strategies in patients with high-risk coronary artery disease and 50-90% angiographic stenosis: a plaque burden and vulnerability-based revascularization strategy guided by intravascular i…
Phase: NA • Sponsor: Bon-Kwon Koo • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a liver drug help people with HIV? new trial aims to find out
Disease control Recruiting nowThe purpose of this research study is to test the safety and effectiveness of the study drug, resmetirom, in participants with MASLD and HIV. This is a research study to test a drug that is already on the market with a population that was not included in the original clinical tri…
Phase: PHASE2 • Sponsor: Naga P. Chalasani • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Hope for kids with rare bone disorder: new drug shows promise in Long-Term trial
Disease control ENROLLING_BY_INVITATIONPhase 2, multicenter, OLE study to evaluate the long-term safety, tolerability, and efficacy of infigratinib, an FGFR (fibroblast growth factor receptor) 1-3-selective tyrosine kinase inhibitor, in participants with Hypochondroplasia (HCH) who previously completed ACCEL 2/3, and …
Phase: PHASE2 • Sponsor: QED Therapeutics, a BridgeBio company • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a diabetes drug shield Teens' kidneys?
Disease control Recruiting nowChronic kidney disease (CKD) is highly prevalent in the state of Aguascalientes, Mexico, particularly among adolescents and young adults. Epidemiologic and histologic studies suggest that this burden is largely driven by reduced nephron endowment of prenatal origin, leading to co…
Phase: PHASE4 • Sponsor: Centenario Hospital Miguel Hidalgo • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug combo targets tough cancers in Mid-Stage trial
Disease control Recruiting nowThis is a multicenter, open-label Phase II clinical study. The primary objective is to evaluate the investigator-assessed objective response rate of JS212 and JS213 as monotherapy and in combination regimens in patients with advanced solid tumors. This study aims to explore the s…
Phase: PHASE2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can talk therapy plus yoga and meditation help veterans with PTSD function better?
Symptom relief Recruiting nowThe goal of this clinical trial is to determine whether which types of integrative care, meaning a combination of psychotherapy and mind-body interventions, lead to the most changes in functioning among Veterans with posttraumatic stress disorder (PTSD). The main aims are: 1. To…
Phase: NA • Sponsor: Veterans Medical Research Foundation • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New weekly shot aims to tackle high blood pressure and obesity together
Disease control Recruiting nowA multicenter, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of IBI362 in participants with mild to moderate hypertension complicated by overweight/obesity who have not received antihypertensive drug treatment
Phase: PHASE3 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Experimental Dual-Target CAR-T therapy takes aim at Hard-to-Treat plasma cell cancers
Disease control Recruiting nowThis is a single arm study to evaluate the safety and efficacy of CAR70-BCMA dual-target CAR-T cell therapy for relapsed and refractory plasma cell neoplasms.
Phase: EARLY_PHASE1 • Sponsor: The General Hospital of Western Theater Command • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug duo aims to shrink throat tumors before surgery
Disease control Not yet recruitingThis is a prospective, single-arm, Phase II clinical trial designed to evaluate the efficacy and safety of vibecotamab combined with putelimab in the treatment of locally advanced laryngeal carcinoma.
Phase: PHASE1, PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New taxane drug RP-001 enters human trials for Hard-to-Treat cancers
Disease control Not yet recruitingPhase 1/2a Study of RP-001 in participants with Advanced Malignancies
Phase: PHASE1, PHASE2 • Sponsor: Recurv Pharma Inc • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Can IVIG help premature Babies' lungs? new trial investigates
Disease control Recruiting nowIt is intended to examine the short-term and long-term efficacy and safety of intravenous immunoglobulin(IVIG) for the bronchopulmonary dysplasia in preterms born at 28 weeks and below. Participants will received continuous infusion IVIG 1 g/kg/day for the first 2 days, 0.5 g/kg/…
Phase: PHASE2 • Sponsor: International Peace Maternity and Child Health Hospital • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug aims to ease tough schizophrenia symptoms
Symptom relief Recruiting nowEvaluate the efficacy, as well as safety and pharmacokinetics, of Roluperidone in improving the negative symptoms of schizophrenia in adult subjects in Phase A of study, followed by Phase B of study to evaluate the relapse rate of Roluperidone and antipsychotic medications.
Phase: PHASE3 • Sponsor: Minerva Neurosciences • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Could allergy and COPD drugs tame rheumatoid arthritis?
Disease control Recruiting nowRheumatoid arthritis is a chronic inflammatory disease that causes joint pain, swelling, and disability. Although standard disease-modifying antirheumatic drugs (DMARDs) are effective for many patients, some individuals continue to experience active disease and inflammation. The …
Phase: PHASE2 • Sponsor: Horus University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Simple blood test could spot hidden liver disease in women
Diagnosis OngoingPrimary biliary cholangitis (PBC) is a chronic autoimmune disease characterized by progressive destruction of the small intrahepatic bile ducts, leading to cholestasis and potential progression to cirrhosis. Prognosis is favorable when diagnosed and treated early, while diagnosti…
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
Can an older antibiotic combo fight sepsis and superbugs?
Disease control Recruiting nowNorwegian guidelines for empirical antibiotic therapy in suspected community acquired sepsis recommend the combination of narrow spectrum betalactam and aminoglycoside as the first choice, but broad spectrum betalactams are considered equally appropriate, effective, and safe. How…
Phase: PHASE4 • Sponsor: University Hospital, Akershus • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy aims to help leukemia survivors shed pounds
Disease control Recruiting nowThis is a 28-week, single-arm, open-label phase II clinical trial evaluating the combination of Tirzepatide and remote, supervised, tailored resistance exercise training to achieve weight loss in adult survivors of childhood acute lymphoblastic leukemia (ALL) living with obesity …
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New pill aims to unclog arteries in heart disease patients
Disease control Recruiting nowThis is a multicenter, randomized, double-blind, placebo parallel controlled study to evaluate the preliminary efficacy, safety, and PopPK profile of ABP-745 in patients with ASCVD. Efficacy of ABP-745 in reducing atherosclerotic plaque compared with placebo will be evaluated in …
Phase: PHASE2 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC